Daiichi Sankyo Co Ltd
TSE:4568
Daiichi Sankyo Co Ltd
Total Equity
Daiichi Sankyo Co Ltd
Total Equity Peer Comparison
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Daiichi Sankyo Co Ltd
TSE:4568
|
Total Equity
¥1.7T
|
CAGR 3-Years
10%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Total Equity
¥7.3T
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
11%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Total Equity
¥2.5T
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
5%
|
|
S
|
Shionogi & Co Ltd
TSE:4507
|
Total Equity
¥1.2T
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Total Equity
¥1.6T
|
CAGR 3-Years
19%
|
CAGR 5-Years
17%
|
CAGR 10-Years
11%
|
|
Astellas Pharma Inc
TSE:4503
|
Total Equity
¥1.6T
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
See Also
What is Daiichi Sankyo Co Ltd's Total Equity?
Total Equity
1.7T
JPY
Based on the financial report for Mar 31, 2024, Daiichi Sankyo Co Ltd's Total Equity amounts to 1.7T JPY.
What is Daiichi Sankyo Co Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
6%
Over the last year, the Total Equity growth was 17%. The average annual Total Equity growth rates for Daiichi Sankyo Co Ltd have been 10% over the past three years , 6% over the past five years , and 6% over the past ten years .